- First Indian anti-cancer drug launches in China
- FDA approves emergency booster dose of Moderna’s COVID-19 vaccine
- EMA begins real-time review of AstraZeneca’s COVID antibody cocktail
- Abbott Labs recalls two COVID test kits after false positives
- Anticancer Bioscience receives additional $10.6 investment into cancer therapy
- Lexeo Therapeutics and FUJIFILM announce partnership to co-develop gene therapies
- WHO’s new taskforce “last chance” to track COVID origins
- UCL: Lateral flow test more accurate than previously thought
- Verona Pharma to present Phase II data with pMDI for COPD patients
- Empagliflozin (Jardiance®) receives SMC approval for treatment of heart failure
- Gavi to purchase 176.5 million doses of Moderna COVID-19 vaccine for low income countries
- Symbiosis Pharma to manufacture Modus’ sepsis treatment
- Investment into mid-stage tech companies reaches new heights
- SMC announces first long-acting injectable HIV treatment
- AstraZeneca’s antibody cocktail cuts risk of severe COVID in half, study finds